{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Chimerism analysis of peripheral blood mononuclear cells using PCR for STR/VNTR will be performed post transplant. On each occasion, the peripheral blood will be separated into the T-cell component (using e.g. CD3 selection) and the myeloid component (using e.g.CD14/15 selection) before assessment of chimerism.","groups":[{"description":"patients receiving transplant using ATG/Bu/Flu/Cy per this protocol","id":"OG000","title":"Transplant Recipients"}],"paramType":"NUMBER","populationDescription":"only 15 of the patients treated on study had Day 30 chimerism results.","reportingStatus":"POSTED","timeFrame":"Day 30","title":"Achievement of > 90% (Full) Donor Chimerism in the T-cell Lineage as Measured by PCR at Day 30 Post-transplantation","type":"PRIMARY","unitOfMeasure":"participants"}